APPROVAL OF Pfizer's COVID-19 vaccine for young children may not occur until November. The company said Tuesday that it had provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old. / AP FILE PHOTO/JOHN LOCHER
WASHINGTON (AP)– Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November. The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old.…